At a glance
This program funds innovative pancreatic cancer research focused on supportive care, quality of life, and survivorship. It can support clinical research studies and may include preliminary data, but it does not allow clinical trials or preclinical animal studies. Eligible applicants include extramural and intramural U.S. Department of War organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities; investigators at any career level, including postdoctoral and clinical fellows, may be named PI. The award is a grant with a maximum period of 2 years and total costs capped at $0.3 million per award, and cost sharing is not required. The program expects to fund about four awards and notes no geographic restriction beyond eligibility tied to U.S. Department of War organizations.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Focused Pilot Award supports the exploration and development of impactful and innovative concepts under a patient-centered focus area of pancreatic cancer research that could ultimately lead to major advancements that will have a profound effect on patients’ overall quality of life. The research this award supports should strive to produce robust preliminary data that can serve as a foundation for future clinical or real-world research application. Distinctive Features: This award mechanism allows, but does not require, preliminary data. Applications can support clinical research studies; however, this mechanism does not allow clinical trials. Preclinical animal studies do not meet the intent of this mechanism.
Who can apply
- Unrestricted